Paper · 206649
Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.
Zarling JM and 1 other. J Exp Med, 1978. Cited by 41 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines. Papers, record 206649. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/206649
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Lymphocytes | Major topic |
| B-Lymphocytes | |
| Cell Line | |
| Cell Transformation, Viral | |
| Cross Reactions | |
| Herpesvirus 4, Human | |
| Histocompatibility Antigens | |
| Humans | |
| Lymphocyte Activation | |
| T-Lymphocytes |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 74,499 | Pool-priming: A means of generating T lymphocytes cytotoxin to tumour or virus-infected cells. | Lancet | 1978 | https://conductscience.org/library/papers/74499 | PubMed |
| 2 | 63,354 | Preliminary amino acid sequences of transplantation antigens: genetic and evolutionary implications. | Contemp Top Mol Immunol | 1976 | https://conductscience.org/library/papers/63354 | PubMed |
| 3 | 67,153 | Studies on H-2 specificities on mouse tumour cells by a new microradioassay. | J Immunogenet | 1977 | https://conductscience.org/library/papers/67153 | PubMed |
| 4 | 197,258 | Clonal transformation of adult human leukocytes by Epstein-Barr virus. | J Virol | 1977 | https://conductscience.org/library/papers/197258 | PubMed |
| 5 | 973,137 | Derepressed alloantigen in transplacentally induced lung tumor coded for by H-2 linked gene. | Science | 1976 | https://conductscience.org/library/papers/973137 | PubMed |
| 6 | 4,122,454 | Cellular reactions against Burkitt lymphoma cells. 3. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells. | Int J Cancer | 1972 | https://conductscience.org/library/papers/4122454 | PubMed |
| 7 | 4,137,183 | Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells. | Scand J Immunol | 1974 | https://conductscience.org/library/papers/4137183 | PubMed |
| 8 | 4,204,524 | New genetic model for allelism at histocompatibility and other complex loci: polymorphism for control of gene expression. | Transplant Proc | 1973 | https://conductscience.org/library/papers/4204524 | PubMed |
| 9 | 53,262 | Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis. | J Exp Med | 1975 | https://conductscience.org/library/papers/53262 | PubMed |
| 10 | 52,628 | Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies. | Int J Cancer | 1975 | https://conductscience.org/library/papers/52628 | PubMed |
1 to 10 of 13
See all 13 referencesCited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,604,571 | Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6604571 | PubMed |
| 6,553,506 | The role of allogeneic cells in the stimulation of cell-mediated cytotoxicity to leukaemia cells. A family study. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6553506 | PubMed |
| 6,450,603 | In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6450603 | PubMed |
| 3,262,014 | In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/3262014 | PubMed |
| 3,160,380 | Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3160380 | PubMed |
| 3,044,461 | Graft versus leukemia in bone marrow transplantation. | Blut | 1988 | https://conductscience.org/library/papers/3044461 | PubMed |
| 2,944,973 | Heterogeneous cytotoxic cells that kill NC-sensitive WEHI-164 tumor cells are activated in allogeneic mixed lymphocyte reactions. | Immunol Res | 1986 | https://conductscience.org/library/papers/2944973 | PubMed |
| 217,013 | Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/217013 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/206649
GET https://conductscience.org/api/papers/v1/206649/authors